J Korean Diabetes.  2021 Dec;22(4):238-243. 10.4093/jkd.2021.22.4.238.

Body Composition and Diabetes

• Yoo HJ

• KMID: 2526206
• DOI: http://doi.org/10.4093/jkd.2021.22.4.238

Abstract

Representative body composition related to metabolic diseases in our body include fats and muscles, and accumulation of abdominal fats and loss of muscles caused by aging are the main causes of type 2 diabetes mellitus. Such changes in body composition vary according to sex and age; in particular, women exhibit significant changes, especially during menopause. Therefore it is necessary to determine new anthropometric indicators that reflect differences in muscles and fats mass changes caused by aging, as well as their distributions, and to establish diagnostic criteria for stratifying the risks of metabolic diseases in both men and women. This article summarizes the underlying mechanisms and recent epidemiological findings that support how muscles decrease and visceral fats increase the risk of type 2 diabetes mellitus.

Keyword

Body composition; Diabetes mellitus; Fats; Muscles

Reference

1.Felig P. The glucose-alanine cycle. Metabolism. 1973. 22:179–207.

2.Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994. 372:425–32.

3.Grimby G., Saltin B. The ageing muscle. Clin Physiol. 1983. 3:209–18.

4.Visser M., Pahor M., Tylavsky F., Kritchevsky SB., Cauley JA., Newman AB, et al. One- and two-year change in body composition as measured by DXA in a population-based cohort of older men and women. J Appl Physiol (1985). 2003. 94:2368–74.

5.Lexell J. Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci. 1995. 50(Spec No:11-6):

6.Koster A., Visser M., Simonsick EM., Yu B., Allison DB., Newman AB, et al. Association between fitness and changes in body composition and muscle strength. J Am Geriatr Soc. 2010. 58:219–26.

7.Siervogel RM., Wisemandle W., Maynard LM., Guo SS., Roche AF., Chumlea WC, et al. Serial changes in body composition throughout adulthood and their relation-ships to changes in lipid and lipoprotein levels. The Fels Longitudinal Study. Arterioscler Thromb Vasc Biol. 1998. 18:1759–64.

8.Jensen MD. Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008. 93(11 Suppl 1):S57–63.

9.Fox CS., Massaro JM., Hoffmann U., Pou KM., Mau-rovich-Horvat P., Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007. 116:39–48.

10.Chau YY., Bandiera R., Serrels A., Martínez-Estrada OM., Qing W., Lee M, et al. Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source. Nat Cell Biol. 2014. 16:367–75.

11.Cree MG., Newcomer BR., Katsanos CS., Sheffield-Moore M., Chinkes D., Aarsland A, et al. Intramuscular and liver triglycerides are increased in the elderly. J Clin Endocrinol Metab. 2004. 89:3864–71.

12.Kuk JL., Saunders TJ., Davidson LE., Ross R. Age-related changes in total and regional fat distribution. Ageing Res Rev. 2009. 8:339–48.

13.Manolopoulos KN., Karpe F., Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond). 2010. 34:949–59.

14.Folsom AR., Kaye SA., Sellers TA., Hong CP., Cerhan JR., Potter JD, et al. Body fat distribution and 5-year risk of death in older women. JAMA. 1993. 269:483–7.

15.Lobo RA. Estrogen and cardiovascular disease. Ann N Y Acad Sci. 1990. 592:286–94. discussion 334-45.

16.Kannel WB., Hjortland MC., McNamara PM., Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976. 85:447–52.

17.Garg SK., Delaney C., Shi H., Yung R. Changes in adipose tissue macrophages and T cells during aging. Crit Rev Im-munol. 2014. 34:1–14.

18.Blok P., Craanen ME., Offerhaus GJ., Dekker W., Kuipers EJ., Meuwissen SG, et al. Molecular alterations in early gastric carcinomas. No apparent correlation with Helicobacter pylori status. Am J Clin Pathol. 1999. 111:241–7.

19.Hong S., Chang Y., Jung HS., Yun KE., Shin H., Ryu S. Relative muscle mass and the risk of incident type 2 diabetes: a cohort study. PLoS One. 2017. 12:e0188650.

20.Li JJ., Wittert GA., Vincent A., Atlantis E., Shi Z., Appleton SL, et al. Muscle grip strength predicts incident type 2 diabetes: population-based cohort study. Metabolism. 2016. 65:883–92.

21.Park SW., Goodpaster BH., Strotmeyer ES., Kuller LH., Broudeau R., Kammerer C, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007. 30:1507–12.

22.Kim KS., Park KS., Kim MJ., Kim SK., Cho YW., Park SW. Type 2 diabetes is associated with low muscle mass in older adults. Geriatr Gerontol Int. 2014. 14(Suppl 1):115–21.

23.Park SW., Goodpaster BH., Lee JS., Kuller LH., Boudreau R., de Rekeneire N, et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 2009. 32:1993–7.

24.Dalal M., Ferrucci L., Sun K., Beck J., Fried LP., Semba RD. Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women. J Gerontol A Biol Sci Med Sci. 2009. 64:132–7.

25.Saito T., Murata M., Otani T., Tamemoto H., Kawakami M., Ishikawa SE. Association of subcutaneous and visceral fat mass with serum concentrations of adipokines in subjects with type 2 diabetes mellitus. Endocr J. 2012. 59:39–45.

26.Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001. 60:349–56.

27.Boden G. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc Assoc Am Physicians. 1999. 111:241–8.

28.Rothney MP., Catapano AL., Xia J., Wacker WK., Tidone C., Grigore L, et al. Abdominal visceral fat measurement using dual-energy X-ray: association with cardiometabolic risk factors. Obesity (Silver Spring). 2013. 21:1798–802.

29.Nordström A., Hadrévi J., Olsson T., Franks PW., Nordström P. Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. J Clin Endocrinol Metab. 2016. 101:3740–6.

30.Leslie WD., Ludwig SM., Morin S. Abdominal fat from spine dual-energy x-ray absorptiometry and risk for subse-quent diabetes. J Clin Endocrinol Metab. 2010. 95:3272–6.

31.Gupta P., Lanca C., Gan ATL., Soh P., Thakur S., Tao Y, et al. The association between body composition using dual energy X-ray absorptiometry and type-2 diabetes: a systematic review and meta-analysis of observational studies. Sci Rep. 2019. 9:12634.

32.Kim JA., Hwang SY., Chung HS., Kim NH., Seo JA., Kim SG, et al. Proportion and characteristics of the subjects with low muscle mass and abdominal obesity among the newly diagnosed and drug-naïve type 2 diabetes mellitus patients. Diabetes Metab J. 2019. 43:105–13.

33.Khadra D., Itani L., Tannir H., Kreidieh D., El Masri D., El Ghoch M. Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: a systematic review and meta-analysis. World J Diabetes. 2019. 10:311–23.

34.Roh E., Hwang SY., Kim JA., Lee YB., Hong SH., Kim NH, et al. Age- and sex-related differential associations between body composition and diabetes mellitus. Diabetes Metab J. 2021. 45:183–94.